The report marks the first time a state government entity has run over… comprehensive research on psilocybin… adverse reactions to psilocybin listed in the report included… mixing… with other drugs like cannabis… …adverse reactions to psilocybin listed in the report [also] included hypertension, nausea and gastrointestinal complications when consuming whole mushrooms… the report concluded that…
British American Tobacco [BAT] said it wanted to “accelerate” its transformation by reducing the health impact of its products. BAT took a stake in Canadian medical cannabis maker… It also signed a deal to research a new range of adult cannabis products, initially focused on cannabidiol (CBD). Original Article (BBC):Cannabis part of the future says…
…measure is known as the Blumenauer-McClintock-Norton-Lee amendment… …amendment removes the word “medical” from the current language — thereby extending these protections to both qualified patients and to adults, as well as to those licensed in both the medical and recreational industries. Original Article (Norml):Upcoming congressional house vote on marijuana policyArtwork Fair Use: Cannabis Pictures
Closing arguments are expected in the West Virginia trial next week [7/26/21 – 7/30/21]. Local West Virginia communities had opted out of the proposed nationwide deal to pursue one on their own. States will have 30 days to decide whether to join the global accord then more time to try to convince their cities and…
If Bryan Roth… has his way, psychedelics could change forever… “There are plenty of psychedelics out there,” he added. “We don’t need any more psychedelics.” … “They want to transform the treatment of depression, with a pill, basically,” Roth said of DARPA… brought together a “dream team” of scientists to work on the project, including…
…the company is also developing novel molecules based on other psychedelic compounds. The company has filed 12 provisional patent applications for novel psychedelic molecules… Thomas Laughren, a medical doctor who served as the director of the U.S. Food and Drug Administration’s division of psychiatry products for nearly three decades… …left his post at the FDA…
While ibogaine has demonstrated anti-anxiety and anti-depression effects and is used in some drug and alcohol rehab clinics around the world… Ibogaine’s successes – as well as the successes of psilocybin and ketamine — suggest that psychedelics may one day be recognized as powerful medicines… in his lab at University of California Davis Olson wondered whether the psychedelic effects of drugs…
…supports a proposed U.S. legislation to legalize cannabis at the federal level… Amazon was hit with a proposed class action suit, which claimed that the company was violating a New York City law by testing applicants for jobs at local facilities for marijuana… the company does not allow marijuana sales on its platform. Original Article…
It’s not clear if the Department of Justice will issue a new cannabis prosecution guidance memo under… [new head of DEA, Anne Milgram, former Attorney General of New Jersey]… she has publicly stated her opposition to even modest reforms such as state-level efforts to simply decriminalize marijuana [in the past]… William Barr, maintained that Congress…
[These removed California psychedelic decriminalization SB 519 sections] would have had a major impact on getting people out of jail for the possession of drugs that look to be on the verge of decriminalization. We’ve seen a lot of family reunification stories in cannabis over the past few years – it will be nice to…
